尊龙凯时人生就是搏·(中国区)官方网站

VOLUNTARY ANNOUNCEMENT - DATA FROM PHASE III STUDY OF BENMELSTOBART IN COMBINATION WITH ANLOTINIB FOR FIRST-LINE TREATMENT OF SQ-NSCLC PRESENTED IN 2025 ASCO ANNUAL MEETING

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2025

2024 ANNUAL REPORT

GENERAL MANDATES TO ISSUE AND BUY BACK SHARES; RE-ELECTION OF DIRECTORS; ADOPTION OF THE NEW ARTICLES; AND NOTICE OF ANNUAL GENERAL MEETING

NOTICE OF ANNUAL GENERAL MEETING

FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING (OR ANY ADJOURNMENT OR POSTPONEMENT THEREOF)

NOTIFICATION LETTER AND REPLY FORM FOR REGISTERED SHAREHOLDERS

NOTIFICATION LETTER AND REQUEST FORM FOR NON-REGISTERED SHAREHOLDERS